Sonoma Pharmaceuticals Inc (SNOA) — Cash Flow Quality Index

Latest as of June 2020: -2.30x

Sonoma Pharmaceuticals Inc (SNOA) has a Cash Flow Quality Index of -2.30x as of June 2020. Operating cash flow of $-2.28 Million is below net income of $993.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Sonoma Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-2.30x
Operating CF / Net Income

Operating Cash Flow

$-2.28 Million
USD

Net Income

$993.00K
USD

Data as of

Jun 2020
Most recent filing

Sonoma Pharmaceuticals Inc Cash Flow Quality Index (2014–2017)

Historical Cash Flow Quality Index for Sonoma Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see SNOA cash generation efficiency.

Annual Cash Flow Quality Index for Sonoma Pharmaceuticals Inc (2014–2017)

Year-by-year earnings quality comparison for Sonoma Pharmaceuticals Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2017 -0.88x $-8.17 Million $9.27 Million ▲ +32.7%
2014 -1.31x $-4.89 Million $3.73 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.